Prostate Cancer Clinical Trial
Novel Synthetic T2W MR Imaging and Spin Parameter Mapping Techniques for Screening Prostate Cancer
This clinical trial studies examines a 3D magnetic resonance imaging (MRI) compared to standard MRI imaging techniques in screening patients with prostate cancer. Diagnostic procedures, such as MRI, may help find and diagnose prostate cancer. Computer systems that allow doctors to create a 3-dimensional (3-D) picture of the tumor may help in planning.
I. To determine whether the image quality of the novel 3-dimensional (3D) T2-weighted imaging (T2W) synthetic imaging technique without endorectal coil is comparable to the 2-dimensional (2D) T2W imaging technique without endorectal coil.
I. To evaluate the qualitative diagnostic quality of the T2W images provided by the novel 3D technique, as determined by subjective scoring by experienced readers.
I. To investigate the feasibility of novel 3D synthetic imaging and multi-spin parameter mapping technique of prostate for the detection of clinically significant prostate cancer (csPCa).
Patients undergo 3D MRI imaging over 15 minutes with standard of care MRI or at a separate time.
Male, age >= 18
Untreated, biopsy-proven with intermediate and high-risk adenocarcinoma of the prostate
Patient is being considered for curative-intent treatment with radical prostatectomy
Patient has provided written informed consent for participation in this trial
Patient should be eligible for scanning on a 3T magnet
Low-risk adenocarcinoma of prostate
Any prior therapy for prostate cancer
A history of other active malignancy within the last 2 years
Prostate cancer with significant sarcomatoid, spindle cell, or neuroendocrine small cell components
Orthopedic hardware in the pelvis and spine
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.